SCHEMBL19375479

SCHEMBL19375479

CN1c2nc(Cc3cc(OC(F)(F)F)ccc3F)n(Cc3ccc(Cl)cc3)c2C(=O)N(CCCOC2CCCCO2)C1O

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 20/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21499694 0.86 TRPC5 (0.43) P2RX3
SCHEMBL21316333 0.83 P2RX3 (0.40) P2RX3
SCHEMBL19375035 0.83 P2RX3 (0.44) P2RX3
SCHEMBL19505466 0.82 P2RX3 (0.39) P2RX3
SCHEMBL21499666 0.81 P2RX3 (0.43) P2RX3
SCHEMBL20432337 0.81 P2RX3 (0.46) P2RX3
SCHEMBL19375462 0.81 P2RX3 (0.46) P2RX3
SCHEMBL16028234 0.80 TRPC5 (0.50) P2RX3
SCHEMBL21316331 0.78 P2RX3 (0.45) P2RX3
SCHEMBL20656224 0.77 P2RX3 (0.46) P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10399982-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, INC. (US) 2019-09-03 — — US disclosed
EP-2970303-B9 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES INC (US) 2017-09-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10399982-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 P2RX3 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback